Peters, Jaime - University of Exeter

个人简介

PhD (University of Leicester, 2007) MSc (University of Leicester, 2000) BSc (University of Keele, 1998)

研究领域

Jaime's main research interests are in the areas of health economic modelling and evidence synthesis. With respect to modelling, she has a particular interest in the use and inclusion of evidence in such models, e.g. the use of elicitation methods to obtain expert opinion to help inform modelling, and also in the identification of evidence to parameterise decision models. Jaime is mainly involved in the application of evidence synthesis and decision modelling to the evaluation of tests. She has recently been involved in two studies related to the diagnosis of diabetes. One of these (funded by the Wellcome Trust and the Department of Health) concerns the cost-effectiveness of strategies to screen individuals with diabetes to identify those with a genetic form, who may benefit from a change to less invasive and less costly treatment. The second study (funded by the NIHR’s Research for Patient Benefit programme) is a systematic review of the evidence to identify clinical criteria to predict absolute insulin deficiency, a measure of type 1 diabetes. Jaime has also continued her interest in issues of publication and reporting bias in a study looking at the use and impact of a particular reporting guideline for non-randomised studies (TREND).

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Peters J, Fuller T, Pearson M (In Press). Improving the reporting of health and psychological research. Australian Psychologist Full text. Shields BM, Peters JL, Cooper C, Lowe J, Knight BA, Powell RJ, Jones A, Hyde CJ, Hattersley AT (2015). Can clinical features be used to differentiate type 1 from type 2 diabetes? a systematic review of the literature. BMJ Open, 5(11). Abstract. Author URL. Full text. Article has an altmetric score of 6 Peters JL, Cooper C, Buchanan J (2015). Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol. BMJ Open, 5(11). Abstract. Author URL. Full text. Article has an altmetric score of 5 Ciani O, Buyse M, Garside R, Peters J, Saad ED, Stein K, Taylor RS (2015). Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer. Journal of Clinical Epidemiology, 68(7), 833-842. Abstract. Fuller T, Pearson M, Peters J, Anderson R (2015). What affects authors' and editors' use of reporting guidelines? Findings from an online survey and qualitative interviews. PLoS One, 10(4). Abstract. Author URL. Full text. Article has an altmetric score of 21 Fuller T, Peters J, Pearson M, Anderson R (2014). Impact of the transparent reporting of evaluations with nonrandomized designs reporting guideline: ten years on. Am J Public Health, 104(11), e110-e117. Abstract. Author URL. Article has an altmetric score of 7 Hoyle M, Peters J, Crathorne L, Jones-Hughes T, Cooper C, Napier M, Hyde C (2013). Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer. Value Health, 16(2), 288-296. Abstract. Author URL. Peters JL, Anderson R, Hyde C (2013). Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes. BMJ Open, 3(5). Abstract. Full text. Peters JL, Anderson R, Hoyle M, Hyde C (2013). Evolution of a cost-utility model of donepezil for Alzheimer's disease. Int J Technol Assess Health Care, 29(2), 147-154. Abstract. Author URL. Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, Jeffreys M, Davis S, Thokala P, Moxham T, et al (2013). Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model. Age Ageing, 42(1), 14-20. Abstract. Author URL. Article has an altmetric score of 4 Grigore B, Peters J, Hyde C, Stein K (2013). Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment. Pharmacoeconomics, 31(11), 991-1003. Abstract. Author URL. Full text. Article has an altmetric score of 4 Hoyle M, Crathorne L, Peters J, Jones-Hughes T, Cooper C, Napier M, Tappenden P, Hyde C (2013). The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model. Health Technol Assess, 17(14), 1-237. Abstract. Author URL. Full text. Article has an altmetric score of 4 Peters JL, Anderson R (2013). The cost-effectiveness of mandatory 20 mph zones for the prevention of injuries. J Public Health (Oxf), 35(1), 40-48. Abstract. Author URL. Article has an altmetric score of 5 Peters JL, Moreno SG, Phillips B, Sutton AJ (2012). Are we sure about the evidence for zinc in prophylaxis of the common cold?. Expert Review of Respiratory Medicine, 6(1), 15-16. Lu L, Peters J, Roome C, Stein K (2012). Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer. BJU International, 109(8), 1183-1192. Abstract. Lu L, Peters J, Roome C, Stein K (2012). Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia. Int J Technol Assess Health Care, 28(3), 241-248. Abstract. Author URL. Article has an altmetric score of 1 Fuller T, Pearson M, Peters JL, Anderson R (2012). Evaluating the impact and use of Transparent Reporting of Evaluations with Non-randomised Designs (TREND) reporting guidelines. BMJ Open, 2(6). Abstract. Author URL. Full text. Article has an altmetric score of 1 Shields BM, Peters JL, Cooper C, Powell RJ, Knight BA, Hyde C, Hattersley AT (2012). Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol. BMJ Open, 2(6). Abstract. Author URL. Full text. Pearson M, Peters J (2012). Outcome reporting bias in evaluations of public health interventions: evidence of impact and the potential role of a study register. J Epidemiol Community Health, 66(4), 286-289. Abstract. Author URL. Article has an altmetric score of 2 Pearson M, Hunt H, Garside R, Moxham T, Peters J, Anderson R (2012). Preventing unintentional injuries to children under 15 years in the outdoors: a systematic review of the effectiveness of educational programs. Injury Prevention, 18(2), 113-123. Abstract. Full text.